Does nivolumab combined with fluorouracil-based chemotherapy produce higher objective response rate than other immunochemotherapy regimes in metastatic esophageal cancer?

Detalles Bibliográficos
Autores principales: Li, Ying, Shen, Lin, Yin, Xudong, Chen, Zixuan, Chen, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562903/
https://www.ncbi.nlm.nih.gov/pubmed/37822732
http://dx.doi.org/10.1016/j.lanwpc.2023.100926

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10562903/
https://www.ncbi.nlm.nih.gov/pubmed/37822732
http://dx.doi.org/10.1016/j.lanwpc.2023.100926

Ejemplares similares